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A ventricular septal defect (VSD) patch infection with Acremonium species isolated from vegetation and blood culture is de-
scribed. Antifungal treatment was discontinued after 3 months and patient developed relapse. Surgery with prolonged oral
voriconazole was instituted with recovery. We emphasize importance of surgery and prolonged therapy to treat such infections.
1. Background
Acremonium species are present in the environment and
mostly cause superficial and locally invasive infections after
traumatic inoculation. Invasive infections are rare and are
mainly reported in immunocompromised patients. It has
been reported to cause osteomyelitis, sinusitis, arthritis,
peritonitis, and less frequently central nervous system in-
fections [1]. Nosocomial and postsurgical invasive infections
have also been described, in particular Acremonium fun-
gemia associated with central line infection and pacemaker
infection [2, 3]. As invasive infections with Acremonium
species are rare, reliable diagnosis and optimal management
of these infections is challenging. Additionally, the species of
Acremonium are morphologically very similar to each other,
and thus their exact identification is not always possible
despite use of modern DNA based methods. Hence, in most
case reports, the agent is reported only as anAcremonium sp.
[4]. )erapy too is challenging as high MICs against all
systemic antifungals used to treat invasive mycoses have
been reported [5]. Due to inherent resistance and variable
clinical response to antifungals, poor outcome generally is
reported in invasive Acremonium infections. Anecdotal evi-
dence suggests a combination of surgical intervention, when
possible, and amphotericin B for a favorable outcome [5].
Reports describing cardiac infections are even rarer. We are
reporting a case of a 21-year-old male with an infected
ventricular septal defect (VSD) patch, after Tetralogy of Fallot
repair, with Acremonium species associated with fungemia
and septic emboli to the lung, kidneys, liver, and spleen.
2. Case Report
A 21-year-old male with a history of Tetralogy of Fallot
(TOF) repair (with Dacron Patch over a large ventricular
septal defect (VSD)) was admitted with complaints of fever
and weight loss for 2 months and left sided abdominal pain
since 1 week. He was recently admitted with similar com-
plaints to another hospital where he was found to have
a right sided pneumonia and was being treated with in-
travenous ceftriaxone. Later, suspecting infective endo-
carditis, gentamicin was added but as the patient was still
having persistent fevers of 40°C, he was referred to our
hospital. On examination, the patient was of lean built with
grade IV clubbing without cyanosis, and there were no
peripheral stigmata of infective endocarditis. He had a loud
pansystolic murmur on the left sternal edge and had ten-
derness on palpation of the left upper abdomen. His initial
investigations showed a high white blood cell count and
C-reactive protein (CRP) (Table 1). A chest X-ray showed
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left mid and right lower lung zone infiltrates, and an ul-
trasound of the upper abdomen showed an ill-defined
splenic lesion without internal vascularity suggesting ei-
ther an abscess or infarct. )ree sets of blood cultures were
subsequently negative. Echocardiogram showed vegetation
on the VSD patch along with dehiscence, a large VSD, and
moderate right ventricular outflow obstruction. A CT ab-
domen with contrast was done which showed multiple liver,
splenic, and lung abscesses with infarcted left kidney and
thrombus at the bifurcation of the aorta secondary to
the septic embolic phenomenon. Cardiothoracic surgery
consultation was sought, and the patient underwent a redo-
sternotomy and removal of vegetations from right ven-
tricular outflow tract site, removal of Dacron Patch, and
complete repair of TOF. Postoperative echocardiogram did
not show any residual VSD or vegetation, only mild left
ventricular dysfunction and moderately reduced right
ventricle function was seen. )e vegetation removed from
right outflow tract and Dacron Patch was sent for bacterial,
mycobacterial, and mycology cultures. Chocolate, Sheep
Blood (SBA), and MacConkey Agar plates were incubated at
37°C for aerobic culture and a SBA plate incubated anaer-
obically. For fungal culture, tissue was stabbed onto the
surface of Sabouraud’s dextrose (SDA), potato dextrose
(PDA), and Mycosel agar plates incubated at 25°C and an
additional SDA and SBA incubated at 37°C.)e initial Gram
stain and 10% potassium hydroxide (KOH) preparation
revealed clusters of oval conidia and hyphae mistaken for
yeast cells and pseudohyphae as well as septate hyphae.
Patient was empirically started on intravenous amphotericin
deoxycholate at 1mg/kg (40mg/dose), his fever gradually
subsided, and the patient was discharged on amphotericin
and oral voriconazole. Bacterial cultures remained negative,
and a filamentous mould grew from the vegetation at 48 h
that was finally identified phenotypically as Acremonium
species (Figure 1). It grew on all plates except MacConkey
agar. Mycobacterial cultures remained negative. Suscepti-
bilities were performed by E-test® (bioMerieux, France) on
RPMI agar, and the isolate showed an MIC of >32mcg/ml
against amphotericin and 2mcg/ml against voriconazole.
After final identification amphotericin, deoxycholate was
discontinued and oral voriconazole 200mg twice daily was
continued. However, treatment was discontinued at 3
months based on clinical improvement and due to inability
of the patient to bear the cost of the treatment. After 2
months of stopping therapy, patient had recurrence of
symptoms along with new vegetation on the pulmonary
valve. Blood cultures were submitted in BD BACTEC™
aerobic and anaerobic bottles and incubated in the BD
BACTEC 9240 system, as BD BACTEC MYCO/F Lytic
system was not available. )e bottles flagged positive after 3
days of incubation and two sets of blood cultures grew
Acremonium species with similar antifungal susceptibilities
(Figure 2). )e mould was identified on the colony and
microscopic morphology. It was a hyaline mould appearing
in 3 days on solid media, with cream coloured wrinkled
surface and an off-white to tan reverse. By day 6, the colonies
became slightly floccose. On microscopic examination, the
hyphae were thin, hyaline, and septate, with short non-
septate conidiophores giving rise to elliptical conidia
clinging to the philaides in wet masses of 10–20. Molecular
confirmation could not be made; however, the isolate was
phenotypically differentiated from Fusarium and Phiale-
monium species due to colony appearance, absence of
macroconidia, and septations at the base of conidiophores.
Voriconazole was restarted and surgical excision of the
pulmonary valve was performed two months later with
growth of the similar fungus. )e patient was continued on
oral voriconazole for a period of one year with clinical
improvement, improvement in inflammatory biomarkers,
no residual vegetation on repeat echocardiogram, and se-
rially negative blood cultures.
3. Discussion
A rare case of fungal infection of a VSD repair patch with
Acremonium species is described. Diagnosis of this case was
Table 1: Serial white blood cell count (WBC) and inflammatory












liter (L)) 17.7 7.6 8.8 8.9
ESR (mm/hr) 65 14 87 18
CRP (mg/L) 22.1 <0.3 10.8 <0.1
Figure 1: Microscopic image of the slide culture of the isolate from
the prosthetic valve.
Figure 2: Gram stain from the blood culture bottle when the
patient relapsed showing septate hyphae and ellipsoidal blasto-
conidium of Acremonium, mimicking pseudohyphae of candida.
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established by visualization of fungal elements on micros-
copy of vegetation tissue and later from culture. Relapse was
confirmed by growth of a similar fungus in pulmonary valve
tissue and two sets of blood cultures. Identification of all
isolated fungi was determined by the conventional method.
Although ITS region sequencing was performed on the
blood culture isolates, it was not able to give reliable
identification.
Although there have been reports of Acremonium spe-
cies, particularly Acremonium kiliense causing peritonitis
[6], involvement of lung and disseminated infection in
immunocompromised patients [7], there are only few case
reports of cardiac infectionwithAcremonium species (Table 2).
In almost all cases, the infection was of a prosthetic valve or
pacemaker [3, 8–10]. However, there have also been reports
of native valve infective endocarditis with this organism
[11, 12]. )ere have been several reports of fungemia usually
associated with central line associated blood stream infection
and mostly occurring in immunocompromised patients, but
none complicated by associated endocarditis [2, 4, 13].
Acremonium endocarditis has resulted in mortality despite
surgical treatment and intravenous amphotericin (Table 2).
In a case of Acremonium strictum colonization of a pros-
thetic mitral valve, the patient died of multiorgan failure
despite treatment with intravenous caspofungin and later
voriconazole [9]. However, there have been reports of pa-
tients recovering successfully with azole treatment as well
[3, 12]. )e treatment duration has varied for both the cases
that were treated successfully. Intravenous fluconazole at
high doses was given for one month with success, and in
another case, patient was treated with intravenous vor-
iconazole initially and later with an oral formulation for six
weeks duration and had an uneventful recovery [3]. Our
patient was treated with surgical intervention as well as with
voriconazole for three months initially but unfortunately
relapsed and was subsequently treated for a whole year.
)e case report that we have described is the first one
from our region and unlike most other cases with adverse
outcome, our patient recovered despite having advanced
disease. Based on our review of other case reports as well as
our own experience, we would recommend surgical in-
tervention along with voriconazole therapy for a prolonged
duration for better outcome in patients having Acremonium
endocarditis.
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